We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $28.2B
1-Year Est. Return 115.26%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
AUM
$16.5B
AUM Growth
Cap. Flow
+$15.4B
Cap. Flow %
93.32%
Top 10 Hldgs %
30.25%
Holding
321
New
321
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 35.76%
2 Healthcare 18.36%
3 Financials 13.71%
4 Communication Services 11.94%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDB icon
276
HDFC Bank
HDB
$121B
$918K 0.01%
+25,402
New +$810K
BRKR icon
277
Bruker
BRKR
$8.14B
$915K 0.01%
+16,904
New +$811K
CHNG
278
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$825K 0.01%
+44,248
New +$727K
QURE icon
279
uniQure
QURE
$3.22B
$796K ﹤0.01%
+22,031
New +$929K
CHE icon
280
Chemed
CHE
$7.22B
$758K ﹤0.01%
+1,423
New +$699K
LHCG
281
DELISTED
LHC Group LLC
LHCG
$720K ﹤0.01%
+3,377
New +$719K
CNMD icon
282
CONMED
CNMD
$1.47B
$701K ﹤0.01%
+6,256
New +$592K
TCMD icon
283
Tactile Systems Technology
TCMD
$665M
$608K ﹤0.01%
+13,527
New +$538K
ACH
284
Accendra Health
ACH
$214M
$597K ﹤0.01%
+22,054
New +$567K
NTB icon
285
Bank of N.T. Butterfield & Son
NTB
$2.45B
$596K ﹤0.01%
+19,125
New +$562K
OCUL icon
286
Ocular Therapeutix
OCUL
$2.02B
$570K ﹤0.01%
+27,539
New +$409K
VIVO
287
DELISTED
Meridian Bioscience Inc
VIVO
$565K ﹤0.01%
+30,237
New +$565K
RCM
288
DELISTED
R1 RCM Inc. Common Stock
RCM
$513K ﹤0.01%
+21,343
New +$424K
UTHR icon
289
United Therapeutics
UTHR
$23.1B
$498K ﹤0.01%
+3,283
New +$431K
ICUI icon
290
ICU Medical
ICUI
$4.61B
$477K ﹤0.01%
+2,223
New +$431K
VCEL icon
291
Vericel Corp
VCEL
$2.31B
$399K ﹤0.01%
+12,908
New +$307K
ACHC icon
292
Acadia Healthcare
ACHC
$2.94B
$391K ﹤0.01%
+7,779
New +$310K
SPNE
293
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$347K ﹤0.01%
+19,901
New +$303K
ZLAB icon
294
Zai Lab
ZLAB
$2.62B
$336K ﹤0.01%
+2,482
New +$253K
ITCI
295
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$336K ﹤0.01%
+10,558
New +$277K
HQY icon
296
HealthEquity
HQY
$8.75B
$305K ﹤0.01%
+4,381
New +$272K
RGEN icon
297
Repligen
RGEN
$9.25B
$289K ﹤0.01%
+1,509
New +$275K
SILK
298
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$287K ﹤0.01%
+4,554
New +$283K
EHTH icon
299
eHealth
EHTH
$43.9M
$281K ﹤0.01%
+3,984
New +$303K
ESTA icon
300
Establishment Labs
ESTA
$2.28B
$240K ﹤0.01%
+6,367
New +$168K

Similar funds

Polar Capital Holdings's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Polar Capital Holdings, which disclosed 321 positions worth $16.5B. Its ten largest holdings account for 30% of the portfolio.

Its largest position is Apple: 5,788,169 shares worth $768M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, followed by Healthcare and Financials.

  • Polar Capital Holdings's largest Q4 2020 buy was Apple: 5,788,169 shares worth $768M.
  • Polar Capital Holdings's ten largest holdings make up 30% of its $16.5B portfolio in Q4 2020.
  • Polar Capital Holdings disclosed 321 positions in Q4 2020, its first 13F filing on record.

Based on Polar Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.